Origin Therapeutics Holdings (XCNQ:ORIG) Debt-to-Asset : 0.00 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Debt-to-Asset?

Origin Therapeutics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was C$0.00 Mil. Origin Therapeutics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was C$0.00 Mil. Origin Therapeutics Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was C$3.19 Mil. Origin Therapeutics Holdings's debt to asset for the quarter that ended in Jun. 2023 was 0.00.

Origin Therapeutics Holdings Debt-to-Asset Historical Data

The historical data trend for Origin Therapeutics Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Debt-to-Asset Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Debt-to-Asset

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Debt-to-Asset	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Debt-to-Asset falls into.

Origin Therapeutics Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Origin Therapeutics Holdings's Debt-to-Asset for the fiscal year that ended in Sep. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	5.588
	=	0.00

Origin Therapeutics Holdings's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	3.191
	=	0.00

Origin Therapeutics Holdings (XCNQ:ORIG) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Origin Therapeutics Holdings Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.